Sort   by:  
 Page size 
UnknownNeoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Not available
S-EPMC9844511 | biostudies-literature
UnknownThe relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response.
Not available
S-EPMC6047673 | biostudies-literature
UnknownActionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans.
Not available
S-EPMC10243786 | biostudies-literature
UnknownRamucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Not available
S-EPMC6946880 | biostudies-literature
UnknownCOVID-19 Pandemic Prompts a Paradigm Shift in Global Emergency Medicine: Multidirectional Education and Remote Collaboration.
Not available
S-EPMC7821062 | biostudies-literature
UnknownAtezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
Not available
S-EPMC8189598 | biostudies-literature
UnknownTriplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
Not available
S-EPMC10040899 | biostudies-literature
UnknownEffect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial.
Not available
S-EPMC4698980 | biostudies-literature
UnknownEfficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
Not available
S-EPMC8700279 | biostudies-literature
UnknownAntiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.
Not available
S-EPMC4481320 | biostudies-literature
Sort   by:  
 Page size